Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Giles Davis

Showing results (1-10 of 36) with videos related to

Pageof 4
Sort By:
The Veterinary Record|January 7, 2014
Reporting suspected adverse eventsGiles Davis
The Veterinary Record|January 31, 2012
Discrepancies in the Controlled Drug register due to the use of products marketed in multi-dose presentationsGiles Davis
The Veterinary Record|October 31, 2015
Using the VMD's product information databaseSuzanne Eckford, Giles Davis
The Veterinary Record|September 7, 2014
Use of Pexion tablets for dogsGiles Davis, Gillian Diesel
The Veterinary Record|October 10, 2015
Adverse events relating to dispensing errorsGillian Diesel, Giles Davis
Cancer Gene Therapy|May 1, 2004
DNA vaccines against the human papillomavirus type 16 E6 or E7 oncoproteinsAnthony P Wlazlo, Hongying Deng, Wynetta Giles-Davis, et al.
Journal of Immunological Methods|August 1, 2000
Staining of antigen activated lymphocytes (SAAL): a highly specific method for flow cytometric quantitation of tumor-specific CD8(+) T cellsD W Kowalczyk, A P Wlazlo, W Giles-Davis, et al.
Gene Therapy|September 1, 1999
The effect of CpG sequences on the B cell response to a viral glycoprotein encoded by a plasmid vectorS Pasquini, H Deng, S T Reddy, et al.
Hybridoma|October 18, 2001
Generation and characterization of monoclonal antibodies against the E6 and E7 oncoproteins of HPVA P Wlazlo, W Giles-Davis, A Clements, et al.
Journal of Immunology (Baltimore, Md. : 1950)|October 21, 2005
Dendritic cell maturation, but not CD8+ T cell induction, is dependent on type I IFN signaling during vaccination with adenovirus vectorsScott E Hensley, Wynetta Giles-Davis, Kimberly C McCoy, et al.
Pageof 4

Showing results (1-10 of 36) with videos related to

Sort By:
Pageof 4
The Veterinary Record|January 7, 2014
Reporting suspected adverse eventsGiles Davis
The Veterinary Record|January 31, 2012
Discrepancies in the Controlled Drug register due to the use of products marketed in multi-dose presentationsGiles Davis
The Veterinary Record|October 31, 2015
Using the VMD's product information databaseSuzanne Eckford, Giles Davis
The Veterinary Record|September 7, 2014
Use of Pexion tablets for dogsGiles Davis, Gillian Diesel
The Veterinary Record|October 10, 2015
Adverse events relating to dispensing errorsGillian Diesel, Giles Davis
Cancer Gene Therapy|May 1, 2004
DNA vaccines against the human papillomavirus type 16 E6 or E7 oncoproteinsAnthony P Wlazlo, Hongying Deng, Wynetta Giles-Davis, et al.
Journal of Immunological Methods|August 1, 2000
Staining of antigen activated lymphocytes (SAAL): a highly specific method for flow cytometric quantitation of tumor-specific CD8(+) T cellsD W Kowalczyk, A P Wlazlo, W Giles-Davis, et al.
Gene Therapy|September 1, 1999
The effect of CpG sequences on the B cell response to a viral glycoprotein encoded by a plasmid vectorS Pasquini, H Deng, S T Reddy, et al.
Hybridoma|October 18, 2001
Generation and characterization of monoclonal antibodies against the E6 and E7 oncoproteins of HPVA P Wlazlo, W Giles-Davis, A Clements, et al.
Journal of Immunology (Baltimore, Md. : 1950)|October 21, 2005
Dendritic cell maturation, but not CD8+ T cell induction, is dependent on type I IFN signaling during vaccination with adenovirus vectorsScott E Hensley, Wynetta Giles-Davis, Kimberly C McCoy, et al.
Pageof 4